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Background/aim: Biomarkers are useful for diagnosing infection and sepsis in adults, but data are limited in elderly patients.
Furthermore, clinical symptoms of infection in elderly patients are usually atypical or unclear. We aimed to assess the usefulness of PCT,
CRP, and WBC in distinguishing elderly patients infected with sepsis from infected without sepsis and those with no-infection. We also
aimed to find a cut-off value for diagnosing sepsis and infection without sepsis in elderly critically ill patients.
Materials and methods: In this single-center and prospective observational study, patients older than 65 years were enrolled. Serum
levels of PCT, CRP, and WBC were measured within 24 h. Patients were allocated into sepsis (S), infected without sepsis (IWS), and noinfection (NI) groups. Data were analyzed with Mann–Whitney U test and Kruskal–Wallis test.
Results: We analyzed 188 patients with a mean age of 77.05 ± 7.4 in the study; 95 (50.5%) of them were women. Sixty-four (34%) of
whom were classified as IWS, 29 (15%) as S, and 95 (50.5%) as NI group. There were significant differences in the PCT, CRP levels
between the IWS and NI, S and NI (p < 0.001, p < 0.001, p < 0.001, p < 0.01, respectively). The PCT levels were significantly different
when the NI group was compared to IWS (p < 0.001) and S (p < 0.001) groups. The CRP levels were also different when the NI group
was compared to both IWS (p < 0.001) and S (p < 0.001). The PCT cut-off values were 0.485 μ/L and 1.245 μg/L for the discrimination
of patients with IWS and S, respectively. The cut-off values of CRP level were 59.45 mg/L and 57.50 mg/L for infected without sepsis
and sepsis, respectively.
Conclusion: PCT was found to be a more valuable marker than CRP and WBC for the discrimination of elderly patients with infected
without sepsis and sepsis.
Key words: Aged, procalcitonin, C-reactive protein, infections, sepsis

1. Introduction
The proportion of elderly patients admitted to the intensive
care unit (ICU) has gradually increased throughout the past
decades as a result of demographic alterations (1). Bacterial
infection is one of the leading causes of hospitalization and
death in the elderly population (2). Although malnutrition
and age-related physiological and anatomical changes are
important causes of increased susceptibility to infectious
diseases in the elderly, the leading cause is decreased
immune function (3). Because of this deficient immune
response in elderly patients, bacterial infections present
with atypical features, such as low or no fever and
irregular leukocytosis, which challenge the physician in
their diagnosis (4). However, early and accurate diagnosis
of bacterial infection and appropriate antimicrobial

treatment is associated with better outcomes (5). Several
studies and meta-analyses have shown that procalcitonin
(PCT) and other inflammatory blood markers [C-reactive
protein (CRP) and white blood cells (WBC)] are reliable
diagnostic markers of bacterial infection in the adult
population (6–8). However, the values of biomarkers for
diagnosing bacterial infection and sepsis have not been
sufficiently determined in elderly patients (9–11).
The purpose of our study to investigate the
discriminative value of serum PCT, CRP, and WBC levels
in distinguishing sepsis from infected without sepsis and
no-infection, as well as to determine the optimal cut-off
values of PCT and CRP for infection and sepsis in elderly
critically ill patients.
2. Materials and methods

* Correspondence: kazim.rollas@yahoo.com
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This observational, single-center, prospective study
was performed between January 1st, 2017, and December
1st, 2019. The local ethics committee approved the study
(No. 31829978-050.01.04), and written informed consent
was obtained from all patients or the next of kin.
ICU patients older than age 65 years were enrolled.
Patients were excluded if they had the following conditions:
death within 72 h after ICU admission, antibiotic treatment
for more than 24 h before admission, chemotherapy within
90 days, chronic renal failure, immunosuppressant therapy,
severe trauma or operation, the need for a vasopressor, or
septic shock at admission to the ICU.
The age, sex, and comorbidities of the patients were
recorded. The Simplified Acute Physiology Score (SAPS
II) and the Sequential Organ Failure Assessment (SOFA)
score were calculated. Blood samples for biomarker
measurements (PCT, CRP, WBC) were taken within 24 h
of ICU admission.
Medical records of the patients were reviewed by an
infectious disease specialist, and patients were allocated
into three groups at the end of the first 72 h of ICU
admission: infected without sepsis (IWS), with sepsis (S),
and no-infection (NI).
The infection types were defined considering clinical
symptoms (body temperature > 38 °C or <36 °C, purulent
sputum or urine, chest X-ray or ultrasound exams,
computed tomography, laboratory tests, urine and blood
culture results according to recommendations from the
Centers for Disease Control and Prevention that define
specific types of infection (http://www. cdc.gov/nhsn/
pdfs/pscmanual/17pscnosinfdef_current.pdf (accessed 30
July 2019)).
Sepsis was defined as life-threatening organ
dysfunction caused by a host response to infection (12).
Organ dysfunction was defined as an increase of 2 points
on the SOFA score (12).
2.1. Measurement of biomarkers
Serum PCT levels were measured with the
electrochemiluminescence immunoassay method using
a Roche Cobas E411 device at a reference range of
0.04–0.1 µg/L. Serum CRP levels were assayed via the
nephelometric method using the Beckman Array 360
System at a reference range of 0–5 mg/L. The WBC count
was determined using a hematological cell counter (LH
780 Analyzer, Beckman Coulter Inc., Miami, FL, USA) at a
reference range of 4.2–10.6 × 103/µL.
2.2. Statistical analysis
Means ± standard deviations were calculated for
continuous variables. Normality was assessed using the
Kolmogorov–Smirnov test. Nonnormally distributed
variables were expressed as medians and as minimums
and maximums. Categorical variables were presented as
percentages. The Mann–Whitney test or the Kruskal–
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Wallis test was used, and the corrections were made
Bonferroni test, when appropriate, for the comparison of
continuous variables. Categorical variables were assessed
using the chi-square test. Receiver operating characteristic
(ROC) curves were plotted for PCT, CRP, and WBC levels
to identify infection and sepsis. The areas under the ROC
curve (AUCs) were calculated. AUC values were reported
with 95% confidence intervals (95% CIs), and p < 0.05 was
considered significant. Statistical analysis was performed
with SPSS version 22.0 (SPSS Inc., Chicago, IL, USA).
3.Results
3.1. Study population and baseline characteristics
A total of 1316 patients was admitted to our ICU 590
patients older than age 65 years were screened. Of these
590 patients, 402 were excluded according to the following
conditions: death within 72 h after ICU admission (n =
25), history of recent antibiotic treatment for more than
24 h before admission (n = 258), septic shock, and/or
need for a vasopressor at ICU admission (n = 80), chronic
renal failure (n = 29), or severe trauma (n = 10). Thus, 188
patients with a mean age of 77.05 ± 7.4 and 95 (50.5%)
of whom were women were included in this study for the
final analysis. Sixty-four patients (34%) were assigned to
IWS; 29 (15%) to S; and 95 (50.5%) to NI. Table 1 shows
the baseline characteristics of the patients. Significant
differences existed in the SAPS II and the SOFA scores
between the IWS and NI (p < 0.001 for each score), S and
NI (p < 0.001 for each score), and IWS and S groups (p <
0.01 for each score). Significant differences were measured
in creatinine values between the S and NI (p < 0.001) and
IWS and S (p < 0.001) groups but not between the IWS and
NI groups (p = 0.95).
Compared to patients in the NI group, patients in
the S group had more neurological diseases (p < 0.01).
The number of associated neurological diseases was not
significantly different between the IWS and S groups (p =
0.19) or the IWS and NI groups (p = 0.06). No significant
differences were observed among the three groups in terms
of the existence of other underlying diseases. In the IWS
group, pneumonia (n = 41; 64.0 %) was the most common
infection type, followed by urinary tract infection (UTI;
n = 14; 22.0%) and then skin and soft tissue infection
(n = 9; 14.0%). The most common causes of sepsis were
pneumonia (n = 13; 45%), UTI (n = 11; 38%), biliary tract
infection (n = 3; 10%), and skin and soft tissue infection
(n = 2; 7%).
3.2. Comparison of WBC, PCT, and CRP levels among
IWS, S, and NI groups
In the IWS group (n = 64), the median (minimummaximum) PCT, CRP, and WBC values were 2.5 µg/L
(0.03–48.04), 68.7 (8.2–158.8), and 15.9 (4.2–64.8),
respectively. In the S group (n = 29), the median
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Table 1. General characteristics of elderly patients.
IWS group
(n = 64)

S group
(n = 29)

NI group
(n = 95)

p value*

Age (years) mean ± SD

76.7 ± 7.4

75.9 ± 8.3

77.6 ± 7.2

0.41

Female n (%)

29 (45)

17 (58)

49 (51)

0.46

SAPS score

66 (28–133)

81 (21–133)

41 (21–98)

<0.001

SOFA score

3.5 (2–8)

6 (3–10)

3 (1–5)

<0.001

HF

9

5

26

0.11

IHD

14

4

17

0.85

DM

3

0

6

0.38

COPD

6

1

10

0.50

Neurological disease

12

9

8

<0.01

Cancer

8

4

11

0.94

Two or more underlying diseases

11

6

17

0.70

Peak temperature (°C) (min-max)

37.5 (37.1–38.3)

37.9 (37.5–38.3)

37.0(36.6–37.4)

<0.001

Creatin (mg/dL) (min-max)

1.2 (0.40–3.20)

1.8 (0.8–3.0)

1.1 (0.40–4.20)

<0.001

Underlying diseases (n)

*p values show the results of the Kruskal–Wallis test for continuous variables and results of the chi-square test for categorical
variables, which were conducted to compare the three groups. Pairwise comparisons by Mann–Whitney U test and chisquare test were shown in the results section of the text and summarized below: Significant differences were found in SAPS
II and the SOFA scores between the IWS and NI (p < 0.001 for each score), S and NI (p < 0.001 for each score), and IWS
and S groups (p < 0.01 for each score). Significant differences were found in creatinine values between the S and NI (p <
0.001), IWS and S (p < 0.001) groups, IWS and NI groups (p = 0.95). Compared to patients in the NI group, patients in the
S group had more neurological diseases (p < 0.01).
IWS, infected without sepsis; S, sepsis; NI, no-infection; SAPS, simplified acute physiology; SOFA, sequential organ failure
assessment; HF, heart failure; IHD, ischemic heart disease; DM, diabetes mellitus; COPD, chronic obstructive pulmonary
disease.

(minimum-maximum) PCT, CRP, and WBC values were
18.6 µg/L (0.69–93.6), 88.3 mg/L (13.6–184.2), and 19.7
(3.5–46.1), respectively. In the NI group (n = 95), the
median (minimum-maximum) PCT, CRP, and WBC
values were 0.09 µg/L (0.01–2.6), 10 mg/L (0.9–72.0), and
25.5 × 103/µL (1.4–140.1), respectively (Table 2).
There were significant differences in the PCT levels
between the IWS and NI, S and NI, and IWS and S groups
(p < 0. 001 for each group). Significant differences were
noted in the CRP levels between the IWS and NI groups
and the S and NI groups (p < 0.001 for each comparison)
but not between the IWS and S groups (p = 0.80). The
WBC levels were significantly different between the IWS
and NI groups and between the S and NI groups (p < 0.001
for each difference) but not between the IWS and S groups
(p = 0.07) (Table 3).
3.3. Diagnostic performance of PCT, CRP, and WBC
3.3.1. Infected without sepsis
ROC curves were performed for PCT, CRP, and WBC
levels to identify infections in the IWS group, and the

AUCs were calculated (Figure 1). The PCT level was
a good marker for the discrimination of patients with
IWS; its cut-off point was 0.485 µg/L (sensitivity, 76.56%;
CI: 64.31–86.25; specificity, 85.26%; CI: 76.51–91.70). The
AUC for discriminating patients with IWS according to
PCT was 0.886 (95% CI: 0.84–0.94; p < 0.001). The cut-off
point of the CRP level for the discrimination of patients
with IWS was 59.45 mg/L (sensitivity, 76.56%; CI: 64.31–
86.25, specificity 73.68%; CI: 63.65–82.19), and the AUC
for identification of IWS according to CRP was 0.787 (95%
CI: 0.72–0.86; p < 0.001). The cut-off point of the WBC
level for the discrimination of patients with IWS was 15.40
× 103/µL (sensitivity, 53.12%; CI: 40.23–65.72; specificity,
80.0%, CI: 70.54–87.51), and the AUC for identification of
IWS according to WBC was 0.695 (95% CI: 0.61–0.78; p <
0.001; Table 4).
3.3.2. Sepsis
ROC curves were performed for PCT, CRP, and WBC
levels to identify sepsis in the S group, and AUCs were
calculated (Figure 2). The PCT level was a good marker for
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Table 2. Comparison of PCT, WBC, and CRP levels in patients with IWS, S, and NI group.
IWS group
(n = 64)

S group
(n = 29)

NI group
(n = 95)

p value*

PCT(µg/L)

2.52 (0.03–48.04)

18.6 (0.69–93.6)

0.09 (0.01–2.6)

<0.001

CRP (mg/L)

68.8 (8.2–158.8)

88.3 (13.6–184.2)

25.5 (1.4–140.1)

<0.001

WBC(× 103/µL)

15.9 (4.2–64.8)

19.7 (3.5–46.1)

10 (0.9–72.0)

<0.001

*p values show the Kruskal–Wallis test results for continuous variables that were conducted to compare the
three groups. Pairwise comparisons by Mann–Whitney U test were shown in the results section of the text and
summarized below: There were significant differences in the PCT levels between the IWS and NI, S and NI, and
IWS and S groups (p < 0. 001 for each group). Significant differences were noted in the CRP levels between the
IWS and NI groups and the S and NI groups (p < 0.001 for each comparison) but not between the IWS and S
groups (p = 0.80). The WBC levels were significantly different between the IWS and NI groups and between the
S and NI groups (p < 0.001 for each difference) but not between the IWS and S groups (p = 0.07).
IWS, infected without sepsis; S, sepsis; NI, no-infection; PCT, procalcitonin; CRP, C-reactive protein; WBC,
white blood cells.
Table 3. Comparison of PCT, WBC, and CRP levels in patients with IWS and S group.
IWS group (n = 64)

S group (n = 29)

p value*

PCT (µg/L)

2.52 (0.03–48.04)

18.6 (0.69–93.6)

<0.001

CRP (mg/L)

68.75 (8.2–158.8)

88 (13.6–184.2)

0.80

WBC (× 10 /µL)

15.95 (4.2–64.8)

19.7 (3.5–46.1)

0.07

3

* Pairwise comparisons by Mann–Whitney U test were conducted to compare the two
groups.
IWS, infected without sepsis; S, sepsis; PCT, procalcitonin; CRP, C-reactive protein; WBC,
white blood cells.

the discrimination of patients with S; its cut-off point was
1.245 µg/L (sensitivity, 96.55%; CI: 82.24–99.91; specificity,
95.79%; CI: 89.57–98.84). The AUC for discriminating
patients with S according to PCT was 0.994 (95% CI:
0.99–1.0; p < 0.001). The cut-off point of the CRP level
for the discrimination of patients with S was 57.50 mg/L
(sensitivity, 79.31%; CI: 60.28–92.01; specificity, 71.58%;
CI: 61.40–80.36), and the AUC for identification of S
according to CRP was 0.795 (95% CI: 0.71–0.88; p < 0.001).
The cut-off point of the WBC level for the discrimination
of patients with S was 14.65 ×103/µL (sensitivity, 75.86%;
CI: 56.46–89.70; specificity, 76.84%; CI: 67.06–84.88), and
the AUC for identification of S according to WBC was
0.768 (95% CI: 0.66–0.88; p < 0.001; Table 5).
4. Discussion
In this prospective, observational study, we investigated
the diagnostic value and optimal cut-off points of serum
PCT and CRP levels for sepsis and infection without
sepsis in elderly critically ill patients. Our results showed
that PCT is a more valuable marker for the diagnosis
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of IWS (AUC = 0.886, p < 0.001) and S (AUC=0.994, p
< 0.001) when accompanied by ROC analysis. On the
other hand, we found that PCT is an accurate marker for
distinguishing sepsis from IWS, while CRP and WBC are
not. We also found cut-off levels of PCT (IWS, 0.485 µg/L;
S, 1.245 µg/L) and CRP (IWS, 59.45 mg/L; S, 57.50 mg/L)
for diagnosing IWS and S in elderly patients were higher
than the current standard cut-off levels.
Diagnosis of infection in elderly patients is quite
complicated by age-related changes, absence of symptoms,
such as fever, and comorbidities that make physical
evaluation difficult (13). Although acute phase reactants,
such as leukocyte count, CRP, and PCT, are considered in
the diagnosis of sepsis and bacterial infections in elderly
patients, their reliability and the optimal cut-off points
in the diagnosis of IWS and S have not been sufficiently
determined (9–11).
Similar to our study, numerous studies have confirmed
that PCT levels have a higher specificity than CRP levels for
bacterial infections (9, 14–17). For instance, Lee et al. (9)
found that PCT is both specific and sensitive in the diagnosis
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ROC Curve
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Figure 1. ROC curve analysis of the PCT, CRP, WBC to identify infected without sepsis.
PCT, procalcitonin; CRP, C-reactive protein; WBC, white-blood-cell.
Table 4. The cut-off point of PCT, WBC and CRP levels for discrimination of patients with IWS.
Cut-off point

Sensitivity
(95% CI)

Specificity
(95% CI)

PPV
(95% CI)

NPV
(95% CI)

AUC
(95% CI)

p*

PCT
≥ 0.485 µg/L

76.56 %
(64.31–86.25)

85.26%
(76.51–91.70)

77.78%
(67.93–85.26)

84.38%
(77.48–89.45)

0.886
(0.84–0.94)

<0.001

CRP
≥ 59.45 mg/L

76.56%
(64.31–86.25)

73.68%
(63.65–82.19)

62.22%
(57.69–73.80)

82.35%
(74.68–88.07)

0.787
(0.72–0.86)

<0.001

WBC
≥ 15.40 × 103/uL

53.12%
(40.23–65.72)

80.0%
(70.54–87.51)

64.15%
(52.96–73.99)

71.70%
(65.70–77.01)

0.695
(0.61–0.78)

<0.001

*Higher values of CRP, PCT, and WBC indicate stronger evidence for Infected without sepsis. PCT, procalcitonin; CRP, C-reactive
protein; WBC, white blood cells; IWS, infected without sepsis; CI, confidence interval; PPV, positive predictive value; NPV, negative
predictive value; AUC, area under curve.

of infection in elderly patients when leukocytosis is specific
(specificity, 0.86) but poorly sensitive (sensitivity, 0.26),
and they noted that CRP is highly sensitive (sensitivity,
0.91) but nonspecific (specificity, 0.36). In another study,
Lin et al. (17) found that PCT levels were more effective
than CRP levels and WBC count at diagnosing bacterial
infection in patients older than age 65 years with diabetes.
According to the results reported by Lin et al. (17), optimal
PCT cut-off points for diagnosing lung infection, UTI, and
skin and soft tissue infection are, respectively, 0.73 µg/L,

1.48 µg/L, and 0.73 µg/L —all higher than the standard
value (0.25 µg/L).
Despite the predominantly positive results regarding
the superiority of PCT use in the diagnosis of systemic
infections, some studies show that CRP is more useful than
PCT (18–21). In a large retrospective study, serum highsensitivity CRP (hs-CRP) level (cut-off value, 61 mg/L)
at admission was more useful than PCT in the diagnosis
of pneumonia in hospitalized elderly patients (18). In
another study conducted in an emergency department,
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ROC Curve
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Figure 2. ROC curve analysis of the PCT, CRP, WBC to identify sepsis. PCT,
procalcitonin; CRP, C-reactive protein; WBC, white-blood-cell.
Table 5. The cut-off point of PCT, WBC, and CRP levels for discrimination patients with S.
Cut-off point

Sensitivity

Specificity

PPV

NPV

AUC
(95% CI)

p*

PCT ≥1.245
µg/L

96.55%
(82.24–99.91)

95.79%
(89.57–98.84)

87.50%
(72.80–94.82)

98.91%
(92.99–99.84)

0.994
(0.99–1.0)

<0.001

CRP≥ 57.50
mg/L

79.31%
(60.28–92.01)

71.58%
(61.40–80.36)

46.00%
(37.06–55.21)

91.89%
(84.61–95.90)

0.795
(0.71–0.88)

<0.001

WBC≥ 14.65
× 109/uL

75.86%
(56.46–89.70)

76.84%
(67.06–84.88)

50.0%
(39.65–60.35)

91.25%
(84.42–95.25)

0.768
(0.66–0.88)

<0.001

*Higher values of CRP, PCT, and WBC indicate stronger evidence for sepsis. PCT, procalcitonin; CRP, C-reactive protein; WBC, white
blood cells; S, sepsis; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; AUC, area under curve.

which included patients older than age 65 years, the CRP
and erythrocyte sedimentation rate were more reliable
markers for differentiating sepsis from SIRS compared
with PCT, WBC, and interleukin-6 levels (19). Stucker et
al. (20) demonstrated that increased CRP (≥3 mg/L) in
patients older than age 75 years in a geriatric ward was an
independent predictor for the presence of acute infection.
However, the authors did not find a significant relationship
between infection and elevated serum PCT (20). Zhang et
al. (21) found that hs-CRP was not inferior to PCT for
the diagnosis of sepsis and septic shock in patients who
were older than age 85 years. In this study, the optimum
cut-off values of serum PCT and hs-CRP for the diagnosis
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of sepsis were 0.45 µg/L and 74.2 mg/L, respectively
(21). Our results showed PCT levels for diagnosing IWS
and S in this population (IWS, 0.485 µg/L; S, 1.245 µg/L)
was higher than the standard value (0.04–0.1 µg/L). Also,
the optimum cut-off points of CRP levels for diagnosing
IWS and S in this population were higher (IWS, 59.45
mg/L; S, 57.50 mg/L) compared to the standard value (0–5
mg/L).
Although many meta-analyses have investigated the
diagnostic reliability of PCT and CRP in sepsis and local
infection, there is no consensus for proposing a widely
accepted cut-off value for these biomarkers (8, 9,22).
Heterogeneity exists because of differences in cut-off values

ZİNCİRCİOĞLU et al. / Turk J Med Sci
of PCT and CRP used in studies enrolling elderly patients
(9,10,23). In their meta-analysis, Tan et al. (8) found
that the optimal cut-off values of PCT and CRP showed
heterogeneity between 0.76 to 6.03 µg/L and between
12.00 to 90.00 mg/L, respectively, in adult patients with
sepsis. Liu et al. (24) found that the CRP cut-off of 60
mg/L had the best combination of sensitivity (80.7%) and
specificity (96.0%). Another study found that the best cutoff value for PCT in older patients was 1.4 µg/L for the
diagnosis of sepsis, similar to the cut-off result in our study
(25). Patients with chronic kidney disease have higher
PCT levels than the normal baseline, regardless of whether
they receive renal replacement therapy or not (26). In our
study, patients with chronic kidney disease were excluded.
However, PCT clearance varies because of the decrease in
the glomerular filtration rate caused by aging (27,28); this
variation may explain why the PCT cut-off values in our
study were higher than the standard values in the elderly
population.
We noted in our study that leukocytosis was a
moderately sensitive marker for IWS and S. Previous
studies also found that WBC count was moderately useful
(19,29) or useless (23) for ruling in or out bacteremia.
There are some limitations to be considered in our
study. First, our study does not have adult patient control
groups, so whether the values in our study are related to
age or not is still a question to be answered. Our results

indicate the values seen in elderly patients, but we cannot
specify these values as related to age as we did not compare
our patients with an adult patient group to evaluate
differences in CRP and PCT kinetics related to age. Second,
we did not obtain longitudinal data on dynamic changing
trends in PCT, CRP, and WBC levels. Last, we conducted
a single-center study; multicenter studies are needed for
more precise results.
In conclusion, according to the results of our study,
including elderly critically ill patients, the diagnostic
accuracy of PCT for sepsis and infected without sepsis is
higher than that of CRP and WBC. We found that PCT is a
more accurate marker for differentiating infected without
sepsis and sepsis while CRP and WBC are not. More
studies are needed to determine the PCT and CRP kinetics
in elderly patients and identify the optimal cut-off point
for PCT levels at different stages of infection.
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